GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Medifast Inc (NYSE:MED) » Definitions » Price-to-Free-Cash-Flow

Medifast (Medifast) Price-to-Free-Cash-Flow

: 2.50 (As of Today)
View and export this data going back to 1981. Start your Free Trial

As of today (2024-04-19), Medifast's share price is $32.34. Medifast's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $12.94. Hence, Medifast's Price-to-Free-Cash-Flow Ratio for today is 2.50.

The historical rank and industry rank for Medifast's Price-to-Free-Cash-Flow or its related term are showing as below:

MED' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.44   Med: 17.87   Max: 55.1
Current: 2.51

During the past 13 years, Medifast's highest Price-to-Free-Cash-Flow Ratio was 55.10. The lowest was 2.44. And the median was 17.87.

MED's Price-to-Free-Cash-Flow is ranked better than
92.11% of 76 companies
in the Personal Services industry
Industry Median: 10.48 vs MED: 2.51

Medifast's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.88. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $12.94.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Medifast was -18.10% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 3.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 22.60% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 25.70% per year.

During the past 13 years, Medifast's highest 3-Year average Free Cash Flow per Share Growth Rate was 65.30% per year. The lowest was -79.20% per year. And the median was 26.55% per year.


Medifast Price-to-Free-Cash-Flow Historical Data

The historical data trend for Medifast's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medifast Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.89 16.70 41.00 7.31 5.20

Medifast Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.31 5.76 5.06 4.70 5.20

Competitive Comparison

For the Personal Services subindustry, Medifast's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast Price-to-Free-Cash-Flow Distribution

For the Personal Services industry and Consumer Cyclical sector, Medifast's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medifast's Price-to-Free-Cash-Flow falls into.



Medifast Price-to-Free-Cash-Flow Calculation

Medifast's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=32.34/12.937
=2.50

Medifast's Share Price of today is $32.34.
Medifast's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.94.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Medifast  (NYSE:MED) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Medifast Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medifast's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Medifast (Medifast) Business Description

Traded in Other Exchanges
Address
100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Executives
Jeffrey J Brown director 19900 MACARTHUR BLVD, SUITE 570, IRVINE CA 92612
Andrea B Thomas director C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Michael A. Hoer director MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Scott Schlackman director 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Hallquist Constance J. director 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Elizabeth A. Geary director C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Daniel R Chard director, officer: Chief Executive Officer NU SKIN ENTERPRISES, INC., 75 WEST CENTER STREET, PROVO UT 84601
Jonathan Barrett Mackenzie officer: VP, Finance & CAO 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Kevin G Byrnes director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Michael C Macdonald director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
James P. Maloney officer: Chief Financial Officer 415 HOLIDAY DRIVE, PITTSBURGH PA 15220
Ming Xian director MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Carl E Sassano director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Joseph P Kelleman officer: (Interim) CFO 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Timothy G Robinson officer: Chief Financial Officer C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117

Medifast (Medifast) Headlines

From GuruFocus

Medifast Announces Quarterly Dividend

By PRNewswire PRNewswire 06-15-2023

OPTAVIA ACTIVE� Now Available

By PRNewswire 09-13-2023

Medifast Announces First Quarter 2023 Financial Results

By PRNewswire PRNewswire 05-01-2023

Medifast: A High Dividend Yield and Cheap Valuation

By Stavros Georgiadis, CFA 06-14-2023

Medifast, Inc. to Present at the Jefferies Consumer Conference

By PRNewswire PRNewswire 07-15-2022

Medifast Announces Quarterly Dividend

By PRNewswire PRNewswire 03-17-2023